
Abalone Bio and Mount Sinai Publish Preclinical Data on World's First CB2 Antibody Agonists
Abalone Bio characterizes in vitro and ex vivo activities of novel antibody agonists produced by their FAST Platform EMERYVILLE, CA, UNITED STATES, August 12, 2025 /EINPresswire.com/ -- Abalone Bio, the only antibody drug company measuring large-scale …